Insight Molecular Diagnostics Inc. Insider Trading Activity
Every SEC Form 4 insider transaction reported for Insight Molecular Diagnostics Inc. (IMDX), sourced directly from SEC EDGAR and updated as new filings are accepted.
By Trabud · Insider-trading data from SEC EDGAR
Latest filing:
Compiled automatically from SEC EDGAR Form 4 filings and refreshed daily. Figures count purchases (code P) and sales (code S) only — not grants, option exercises, or gifts. How this page is built. Not investment advice.
Quick Answer
Are IMDX insiders buying or selling?
In the last 12 months, Insight Molecular Diagnostics Inc. insiders reported 3 open-market purchases ($5.7M) and 0 sales ($0) — net buying of $5.7M. Since March 2018, Trabud has recorded 74 Form 4 filings for IMDX: 67 buys ($133.6M) and 7 sells ($16.4M).
Source: SEC EDGAR Form 4
Key Statistics (March 2018 – Apr 27, 2026)
Total Form 4 filings
74
SEC EDGAR
Insider filers
21
Insider buys (67)
$133.6M
Insider sells (7)
$16.4M
Insider sentiment
Net buyingNet insider flow of $117.2M in net buying since March 2018, and $5.7M in net buying over the last 12 months.
Recent IMDX insider transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Apr 27, 2026 | Neal C Bradsher | 10% Owner | Purchase | 570.2K | $3.56 | $2.0M | SEC ↗ |
| Apr 20, 2026 | Neal C Bradsher | 10% Owner | Purchase | 182.9K | $3.57 | $652.9K | SEC ↗ |
| Feb 13, 2026 | Neal C Bradsher | 10% Owner | Purchase | 521.7K | $5.75 | $3.0M | SEC ↗ |
| Feb 12, 2025 | Andrea S. James | Chief Financial Officer | Purchase | 97.6K | $2.05 | $200.0K | SEC ↗ |
| Feb 11, 2025 | Patrick W Smith | 10% Owner | Purchase | 1.1M | $2.05 | $2.2M | SEC ↗ |
| Feb 11, 2025 | Neal C Bradsher | 10% Owner | Purchase | 5.2M | $2.05 | $10.6M | SEC ↗ |
| Feb 4, 2025 | Patrick W Smith | 10% Owner | Purchase | 915 | $2.01 | $1.8K | SEC ↗ |
| Jan 31, 2025 | Patrick W Smith | 10% Owner | Purchase | 4.2K | $2.01 | $8.4K | SEC ↗ |
| Jan 15, 2025 | Patrick W Smith | 10% Owner | Purchase | 16.1K | $2.12 | $34.1K | SEC ↗ |
| Dec 28, 2024 | Patrick W Smith | 10% Owner | Purchase | 90.2K | $2.13 | $192.2K | SEC ↗ |
| Dec 26, 2024 | Arno Andrew | Director | Purchase | 12.5K | $2.11 | $26.4K | SEC ↗ |
| Dec 9, 2024 | Andrea S. James | Chief Financial Officer | Purchase | 20.0K | $2.29 | $45.8K | SEC ↗ |
| Oct 4, 2024 | Andrea S. James | Chief Financial Officer | Purchase | 33.7K | $2.97 | $100.0K | SEC ↗ |
| Oct 4, 2024 | Neal C Bradsher | 10% Owner | Purchase | 1.3M | $2.95 | $3.9M | SEC ↗ |
| Apr 15, 2024 | Neal C Bradsher | 10% Owner | Purchase | 2.4M | $2.92 | $7.1M | SEC ↗ |
| Apr 15, 2024 | Josh Riggs | CEO and President | Purchase | 3.4K | $2.95 | $10.0K | SEC ↗ |
| Apr 15, 2024 | Arno Andrew | Director | Purchase | 33.9K | $2.95 | $100.0K | SEC ↗ |
| Jun 16, 2023 | Alfred D Kingsley | Director | Purchase | 30.0K | $0.21 | $6.4K | SEC ↗ |
| Apr 7, 2023 | PURA VIDA INVESTMENTS, LLC | 10% Owner | Purchase | 663.0K | $0.30 | $200.0K | SEC ↗ |
| Apr 6, 2023 | Neal C Bradsher | 10% Owner | Purchase | 26.8M | $0.30 | $8.1M | SEC ↗ |
| Dec 28, 2022 | Arno Andrew | Director | Purchase | 250.0K | $0.35 | $87.9K | SEC ↗ |
| Dec 28, 2022 | John Peter Gutfreund | Director | Purchase | 75.0K | $0.33 | $24.7K | SEC ↗ |
| Dec 27, 2022 | Alfred D Kingsley | Director | Purchase | 25.0K | $0.29 | $7.1K | SEC ↗ |
| Aug 19, 2022 | Andrew J. Last | Director | Purchase | 20.0K | $0.87 | $17.4K | SEC ↗ |
| Aug 19, 2022 | Arno Andrew | Director | Purchase | 15.0K | $0.90 | $13.5K | SEC ↗ |
Showing the 25 most recent of 74 Form 4 filings for Insight Molecular Diagnostics Inc..
Most active IMDX insiders
- Neal C Bradsher17 filings
- Arno Andrew7 filings
- Ronald Asbury Andrews7 filings
- Levine Mitchell S6 filings
- Alfred D Kingsley5 filings
Ask anything about IMDX insider activity
Use Trabud's AI agent to query Insight Molecular Diagnostics Inc.'s Form 4 history in plain English — "Show me IMDX CEO purchases this year" or compare it against any other ticker.
Open the AI agentIMDX insider trading FAQ
Are Insight Molecular Diagnostics Inc. insiders buying or selling?
In the last 12 months, Insight Molecular Diagnostics Inc. insiders reported 3 open-market purchases ($5.7M) and 0 sales ($0) — net buying of $5.7M. Since March 2018, Trabud has recorded 74 Form 4 filings for IMDX: 67 buys ($133.6M) and 7 sells ($16.4M). Over the full record that is net buying of $117.2M.
How many insiders trade IMDX stock?
21 distinct insider filers — officers, directors, 10%+ owners, and investment groups filing jointly — have reported Form 4 transactions for Insight Molecular Diagnostics Inc.. The most recent filing was accepted on Apr 27, 2026.
Where does Trabud get IMDX insider trading data?
All IMDX insider trading data comes directly from official SEC EDGAR Form 4 filings, which corporate insiders must submit within two business days of a transaction under Section 16(a) of the Securities Exchange Act of 1934.